The Latest Cardiac and Vascular News
WALTHAM, Mass.–(BUSINESS WIRE)–Paragonix Technologies, a leading organ transplant company, announced today that it has entered into a definitive agreement to be acquired by Getinge. This strategic acquisition will enhance Getinge’s global healthcare portfolio to also address needs in solid organ […]
WALTHAM, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc., a pioneer in organ transplant technologies and services, announces the annual release of the latest GUARDIAN-Heart Clinical Registry report, shared earlier today at the 44th ISHLT Annual Meeting and Scientific Sessions – one of the […]
WALTHAM, Mass.–(BUSINESS WIRE)–Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the publication of new groundbreaking data reflecting the clinical impact of its flagship advanced preservation device, the Paragonix SherpaPak Cardiac Transport System (CTS), to protect and monitor donor hearts from extended criteria donors. In organ transplantation, an extended criteria donor is defined as having perceived risk factors linked to poor subsequent outcomes, for
In a study assessing high-risk heart donors at the 43rd ISHLT Annual Meeting & Scientific Sessions, GUARDIAN-Heart Registry data indicates a significant reduction in Primary Graft Dysfunction (PGD), a severe post-transplant complication, potentially allowing for an increase in donor hearts […]
GUARDIAN Registry data presented at ACC 2023 has shown use of the Paragonix SherpaPak® Cardiac Transport System was associated with improved outcomes as compared to the use of traditional cold storage in LVAD patients undergoing Heart Transplantation.1 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, […]
Now over 1 in 5 Thoracic Organ Transplants are preserved using Paragonix Advanced Organ Preservation and Tracking Technology CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. is announcing a major milestone of preserving over 2,000 donor organs, providing transplant centers Advanced Organ Preservation […]
Device enables donor lungs to safely travel unprecedented distance of 4,788 Miles with a total ischemic time of over 13 hours CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies announces a milestone achievement for its Paragonix LUNGguard™ System as the device safely completed a record distance for […]
More donor hearts safely traveling long distances with the Paragonix SherpaPak® Cardiac Transport System CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. is announcing a major milestone of 1,000 preserved donor heart transports since it began clinical use in 2018, with its flagship product, the Paragonix […]
University of Florida Health (UF Health) enrolls first patient in the study to further understanding of how advanced donor organ preservation impacts pediatric patient outcomes CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. today announces that the University of Florida Health (UF Health) […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies announced a partnership with Southwest Transplant Alliance (STA) to provide advanced organ preservation technology as part of both organization’s ongoing work to save lives through organ donation and transplantation. Under this new partnership, Paragonix will provide the technology, clinical […]
